Increased hepatic lipogenesis in insulin resistance and Type 2 diabetes is associated with AMPK signalling pathway up-regulation in Psammomys obesus

Bioscience Reports

Volumn 29, Issue 5, 2009, Pages 283-292

  Ben Djoudi Ouadda, Ali ^a,b   Levy, Emile ^a,b   Ziv, Ehud ^c   Lalonde, Geneviève ^a,b   Sané, Alain T ^a,b   Delvin, Edgar ^a,b   Elchebly, Mounib ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Acetyl CoA carboxylase (ACC); AMP activated protein kinase (AMPK); Dyslipidaemia; Insulin resistance; Psammomys obesus; Type 2 diabetes

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE 1; CARBOHYDRATE RESPONSIVE ELEMENT BINDING PROTEIN; CHOLESTEROL; FATTY ACID SYNTHASE; GLUCOSE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; ISOENZYME; MESSENGER RNA; MITOCHONDRIAL ISOFORM OF GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; PHOSPHOLIPID;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; FATTY ACID METABOLISM; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID COMPOSITION; LIPID STORAGE; LIPOGENESIS; LIVER LEVEL; LIVER METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSAMMOMYS OBESUS; SIGNAL TRANSDUCTION; WEIGHT GAIN; ANIMAL; BLOOD; GENETICS; GERBIL; ISOLATION AND PURIFICATION; LIVER; MALE; METABOLISM; UPREGULATION;

GERBILLINAE; PSAMMOMYS OBESUS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; GERBILLINAE; INSULIN; INSULIN RESISTANCE; LIPOGENESIS; LIVER; MALE; PHOSPHOLIPIDS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRIGLYCERIDES; UP-REGULATION;

EID: 70350034157     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1042/BSR20080141     Document Type: Article

References (50)

1. Kahn, B. B., Alquier, T., Carling, D. and Hardie, D. G. (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1, 15-25
2. Cheung, P. C., Salt, I. P., Davies, S. P., Hardie, D. G. and Carling, D. (2000) Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem. J. 346, 659-669
3. Hardie, D. G. and Carling, D. (1997) The AMP-activated protein kinase - fuel gauge of the mammalian cell? Eur. J. Biochem. 246, 259-273
4. Hardie, D. G., Carling, D. and Carlson, M. (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67, 821-855
5. Kemp, B. E., Stapleton, D., Campbell, D. J., Chen, Z. P., Murthy, S., Walter, M., Gupta, A., Adams, J. J., Katsis, F., van, Denderen, B. et al. (2003) AMP-activated protein kinase, super metabolic regulator. Biochem. Soc. Trans. 31, 162-168
6. Winder, W. W. and Hardie, D. G. (1999) AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol. 277, E1-E10
7. Minokoshi, Y., Kim, Y. B., Peroni, O. D., Fryer, L. G., Muller, C., Carling, D. and Kahn, B. B. (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343
8. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K. et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295
9. Tomas, E., Tsao, T. S., Saha, A. K., Murrey, H. E., Zhang, C. C., Itani, S. I., Lodish, H. F. and Ruderman, N. B. (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. U.S.A. 99, 16309-16313
10. Hawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D. and Hardie, D. G. (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271, 27879-27887
11. Hawley, S. A., Boudeau, J., Reid, J. L., Mustard, K. J., Udd, L., Makela, T. P., Alessi, D. R. and Hardie, D. G. (2003) Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2, 28
12. Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A. and Cantley, L. C. (2004) The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. U.S.A. 101, 3329-3335
13. Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M. and Carling, D. (2003) LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13, 2004-2008
14. Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G. and Hardie, D. G. (2005) Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9-19
15. 2+/calmodulin- dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2, 21-33
16. Viollet, B., Foretz, M., Guigas, B., Horman, S., Dentin, R., Bertrand, L., Hue, L. and Andreelli, F. (2006) Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J. Physiol. 574, 41-53
17. Ferre, P., Azzout-Marniche, D. and Foufelle, F. (2003) AMP-activated protein kinase and hepatic genes involved in glucose metabolism. Biochem. Soc. Trans. 31, 220-223
18. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N. et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108. 1167-1174
19. Kawaguchi, T., Osatomi, K., Yamashita, H., Kabashima, T. and Uyeda, K. (2002) Mechanism for fatty acid 'sparing' effect on glucose-induced transcription: regulation of carbohydrateresponsive element-binding protein by AMP-activated protein kinase. J. Biol. Chem. 277, 3829-3835
20. Fryer, L. G., Parbu-Patel, A. and Carling, D. (2002) The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277, 25226-25232
21. Betteridge, D. J. (1999) Diabetic dyslipidaemia. Eur. J. Clin. Invest. 29 (Suppl. 2), 12-16
22. Zoltowska, M., Ziv, E., Delvin, E., Stan, S., Bar-On, H., Kalman, R. and Levy, E. (2001) Circulating lipoproteins and hepatic sterol metabolism in Psammomys obesus prone to obesity, hyperglycemia and hyperinsulinemia. Atherosclerosis 157, 85-96
23. Zoltowska, M., Ziv, E., Delvin, E., Lambert, M., Seidman, E. and Levy, E. (2004) Both insulin resistance and diabetes in Psammomys obesus upregulate the hepatic machinery involved in intracellular VLDL assembly. Arterioscler. Thromb. Vasc. Biol. 24, 118-123
24. Zoltowska, M., Ziv, E., Delvin, E., Sinnett, D., Kalman, R., Garofalo, C., Seidman, E. and Levy, E. (2003) Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes. Diabetes 52, 2539-2545
25. Levy, E., Spahis, S., Ziv, E., Marette, A., Elchebly, M., Lambert, M. and Delvin, E. (2006) Overproduction of intestinal lipoprotein containing apolipoprotein B-48 in Psammomys obesus: impact of dietary n-3 fatty acids. Diabetologia 49, 1937-1945
26. Quayle, K. A., Denton, R. M. and Brownsey, R. W. (1993) Evidence for a protein regulator from rat liver which activates acetyl-CoA carboxylase. Biochem. J. 292, 75-84
27. Kudo, N., Barr, A. J., Barr, R. L., Desai, S. and Lopaschuk, G. D. (1995) High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J. Biol. Chem. 270, 17513-17520
28. Halestrap, A. P. and Denton, R. M. (1973) Insulin and the regulation of adipose tissue acetyl-coenzyme A carboxylase. Biochem. J. 132, 509-517
29. -ΔΔCt method. Methods 25, 402-408
30. Anwer, T., Sharma, M., Pillai, K. K. and Iqbal, M. (2008) Effect of Withania somnifera on insulin sensitivity in non-insulin-dependent diabetes mellitus rats. Basic Clin. Pharmacol. Toxicol. 102, 498-503
31. Kaiser, N., Nesher, R., Donath, M. Y., Fraenkel, M., Behar, V., Magnan, C., Ktorza, A., Cerasi, E. and Leibowitz, G. (2005) Psammomys obesus, a model for environment-gene interactions in type 2 diabetes. Diabetes 54 (Suppl. 2), S137-S144
32. Turner, N. C. and Clapham, J. C. (1998) Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: current status and therapeutic possibilities. Prog. Drug Res. 51, 33-94
33. Davies, S. P., Sim, A. T. and Hardie, D. G. (1990) Location and function of three sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein kinase. Eur. J. Biochem. 187, 183-190
34. Ha, J., Daniel, S., Broyles, S. S. and Kim, K. H. (1994) Critical phosphorylation sites for acetyl-CoA carboxylase activity. J. Biol. Chem. 269, 22162-22168
35. Atkinson, L. L., Kelly, S. E., Russell, J. C., Bar-Tana, J. and Lopaschuk, G. D. (2002) MEDICA 16 inhibits hepatic acetyl-CoA carboxylase and reduces plasma triacylglycerol levels in insulin-resistant JCR:LA-cp rats. Diabetes 51, 1548-1555
36. Krause, U., Bertrand, L. and Hue, L. (2002) Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes. Eur. J. Biochem. 269, 3751-3759
37. Bonnard, C., Durand, A., Vidal, H. and Rieusset, J. (2008) Changes in adiponectin, its receptors and AMPK activity in tissues of diet-induced diabetic mice. Diabetes Metab. 34, 52-61
38. Hardie, D. G. (2003) Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144, 5179-5183
39. Ishii, S., Iizuka, K., Miller, B. C. and Uyeda, K. (2004) Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc. Natl. Acad. Sci. U.S.A. 101, 15597-15602
40. Dentin, R., Girard, J. and Postic, C. (2005) Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 87, 81-86
41. Dentin, R., Benhamed, F., Hainault, I., Fauveau, V., Foufelle, F., Dyck, J. R., Girard, J. and Postic, C. (2006) Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 55, 2159-2170
42. Ziv, E., Kalman, R., Hershkop, K., Barash, V., Shafrir, E. and Bar-On, H. (1996) Insulin resistance in the NIDDM model Psammomys obesus in the normoglycaemic, normoinsulinaemic state. Diabetologia 39, 1269-1275
43. Dentin, R., Benhamed, F., Pegorier, J. P., Foufelle, F., Viollet, B., Vaulont, S., Girard, J. and Postic, C. (2005) Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. J. Clin. Invest. 115, 2843-2854
44. Elam, M. B., Wilcox, H. G., Cagen, L. M., Deng, X., Raghow, R., Kumar, P., Heimberg, M. and Russell, J. C. (2001) Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat. J. Lipid Res. 42, 2039-2048
45. Griffin, M. J. and Sul, H. S. (2004) Insulin regulation of fatty acid synthase gene transcription: roles of USF and SREBP-1c. IUBMB Life 56, 595-600
46. Lopez, J. M., Bennett, M. K., Sanchez, H. B., Rosenfeld, J. M. and Osborne, T. E. (1996) Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid. Proc. Natl. Acad. Sci. U.S.A. 93, 1049-1053
47. Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y., Brown, M. S. and Goldstein, J. L. (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6, 77-86
48. Foretz, M., Carling, D., Guichard, C., Ferre, P. and Foufelle, F. (1998) AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes. J. Biol. Chem. 273, 14767-14771
49. Woods, A., Azzout-Marniche, D., Foretz, M., Stein, S. C., Lemarchand, P., Ferre, P., Foufelle, F. and Carling, D. (2000) Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol. Cell. Biol. 20, 6704-6711
50. Park, H., Kaushik, V. K., Constant, S., Prentki, M., Przybytkowski, E., Ruderman, N. B. and Saha, A. K. (2002) Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J. Biol. Chem. 277, 32571-32577